Screener
Nutex Health Inc. NUTX Debt Issuance Proceeds
Debt Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Nutex Health Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromLinesOfCredit.
The source filing: Nutex Health Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054268
| (In thousands) | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Cash flows from financing activities: | ||
| Proceeds from lines of credit | — | 4,606 |
| Proceeds from notes payable | — | 258 |
| Repayments of lines of credit | (642) | (301) |
| Repayments of notes payable | (2,953) | (5,697) |
| Repayments of finance leases | (3,317) | (2,593) |
| Proceeds from exercise of warrants | 75 | — |
| Cash related to stock repurchases and retirements | (50,688) | — |
Item 1. Financial Statements
FAQ
- What is Nutex Health Inc.'s debt issuance proceeds?
- Nutex Health Inc. (NUTX) reported debt issuance proceeds of $0 in Q2 2026.
- How has Nutex Health Inc.'s debt issuance proceeds changed year-over-year?
- Nutex Health Inc.'s debt issuance proceeds decreased by 100.0% year-over-year, from $742K to $0.
- What is the long-term trend for Nutex Health Inc.'s debt issuance proceeds?
- Over 3 years (2021 to 2025), Nutex Health Inc.'s debt issuance proceeds has grown at a 130.1% compound annual growth rate (CAGR), from $413.92K to $5.04M.
- What does debt issuance proceeds mean?
- Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.
Ask your AI about Nutex Health Inc.'s debt issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude